Insmed (INSM) Capital Leases (2010 - 2026)
Insmed (INSM) posted quarterly Capital Leases of $19.8 million for Q1 2026, down 14.81% year-over-year from $23.3 million in Q1 2025, and down 4.34% quarter-over-quarter from $20.7 million in Q4 2025.
Insmed (INSM) Capital Leases (2010 - 2026) Analysis & Trends
Insmed's Capital Leases history runs 12 years deep, the most recent figure standing at $19.8 million for Q1 2026.
- In Q1 2026, Capital Leases fell 14.81% year-over-year to $19.8 million; the TTM figure through Mar 2026 stood at $19.8 million (down 14.81% YoY), while the FY2025 annual figure was $20.7 million, down 13.9% from the prior year.
- Capital Leases for Q1 2026 stood at $19.8 million, down from $20.7 million in the prior quarter.
- The five-year high for Capital Leases was $29.6 million in Q4 2022, with the low at $19.8 million in Q1 2026.
- The 5-year median for Capital Leases is $24.1 million (2024), against an average of $24.7 million.
- The sharpest annual moves came in 2022 and 2026: Capital Leases surged 110.14% in 2022, then slipped 14.81% in 2026.
- Insmed's Capital Leases stood at $29.6 million in 2022, then slipped by 8.81% to $27.0 million in 2023, then fell by 10.96% to $24.1 million in 2024, then slipped by 13.9% to $20.7 million in 2025, then declined by 4.34% to $19.8 million in 2026.
- Business Quant data shows INSM's Capital Leases at $19.8 million in Q1 2026, $20.7 million in Q4 2025, and $21.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.89 Mn |
| Mar 31, 2026 | 19.82 Mn |
| Dec 31, 2025 | 20.72 Mn |
| Sep 30, 2025 | 21.60 Mn |
| Jun 30, 2025 | 22.44 Mn |
| Mar 31, 2025 | 23.27 Mn |
| Dec 31, 2024 | 24.06 Mn |
| Sep 30, 2024 | 24.84 Mn |
| Jun 30, 2024 | 25.59 Mn |
| Mar 31, 2024 | 26.32 Mn |
| Dec 31, 2023 | 27.03 Mn |
| Sep 30, 2023 | 27.71 Mn |
| Jun 30, 2023 | 28.37 Mn |
| Mar 31, 2023 | 29.02 Mn |
| Dec 31, 2022 | 29.64 Mn |
| Sep 30, 2022 | 22.68 Mn |
| Jun 30, 2022 | 23.14 Mn |
| Mar 31, 2022 | 23.51 Mn |
| Dec 31, 2021 | 14.10 Mn |
| Sep 30, 2021 | 13.81 Mn |